Creative Biolabs offers a wide range of pre-clinical services that enable customers to screen potential efficient drug candidates as well as identify novel therapeutic targets in relevant animal models of human diseases. Our scientists and specialists have extensive experience in assisting our customers with the selection of appropriate models and assays, as well as working together to develop new animal models tailored to meet the specific needs of a particular tested item or discovery program.

Existing well-characterized models of inflammation and immunological disease provided by Creative Biolabs involve skin inflammation, gastrointestinal inflammation, joint inflammation, respiratory diseases, sepsis, EAE, systemic lupus erythematosus disease and so on. Each model is coupled with measurements of different parameters that can be used to evaluate the efficacy of candidate drugs in the preclinical phase. A well-trained group of scientists will be assigned to your project, working closely with you from the initial experimental design to final data analysis, to ensure the most relevant and reliable results can be achieved.

Learn more about the different models of inflammatory and immunological diseases for preclinical research by clicking on the links below:

Rodent Inflammation & Immunological Disease Models

Acute Inflammation

Dermal Inflammation

Rheumatoid Arthritis

Sepsis

Systemic Lupus Erythematosus (SLE)

In addition to the well-established models listed above, our expertise in the new animal model development and model validation from the literature where models can be tailored to a specific project is another strength. Our scientific group will not only assist you in the project design and model selection but also in data analysis. Personalized support will help to inform how the project progresses at every stage of the process, from before the project initiates to after the model is successfully delivered.

Creative Biolabs is happy to share our cutting-edge technology and extensive expertise in rodent disease models to facilitate our clients' research and project development. Please feel free to inquire us for more detailed information if you are interested in any of these models. In case you do not see the models that you are interested in, please contact us and we'll be in touch within 24 hours to let you know if it is feasible.

Reference

  1. Hoogenboom, H.R., 2005. Selecting and screening recombinant antibody libraries. Nature biotechnology23(9), pp.1105-1116.

For Research Use Only.



Online Inquiry
Name:
*Phone:
*E-mail Address:
*Service & Products Interested:
Project Description:
Contact Us USA

Tel:
Fax:
Email:
UK

Tel:
Email:

Germany

Tel:
Email:

Follow us on:
Copyright © 2024 Creative Biolabs.